Medication info
Rabeprazole Sodium 20 mg Tablets

Rabeprazole Sodium 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
NBK Pharmaceuticals Co., Ltd.
Appearance
Pale yellow, round, enteric-coated tablet
Packaging
Domestic use - 28 tablets/Alu-Alu [(14 tablets/Alu-Alu x 2)]
Approval status
Active

MFDS item code 202001722 · Approved 2020.03.12 · Insurance code 054800800

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcer disease (gastric or duodenal), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual dose for adults is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be given orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution because hepatic function is often reduced.
Child dose
The safety of this medicine in children has not been established.

Ingredients

Manufacturer
NBK Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcer disease (gastric or duodenal), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • Helicobacter pylori infected gastric ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat digestive ulcers such as gastric ulcers and duodenal ulcers. It also improves symptoms in patients with erosive or ulcerative gastroesophageal reflux disease, and is effective for long-term maintenance therapy of this condition. In patients with Helicobacter pylori infected gastric ulcers, it is used in conjunction with antibiotics to enhance treatment efficacy. It is also beneficial for the treatment of Zollinger-Ellison syndrome. Overall, it is widely used for relief and treatment of various gastrointestinal-related conditions.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual dose for adults is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be given orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults Administer with caution because hepatic function is often reduced.

Child dose

The safety of this medicine in children has not been established.

Precautions

This medication should not be used in patients who have had hypersensitivity to certain ingredients or benzimidazole derivatives. Patients who are allergic to penicillin or macrolide antibiotics should also be cautious when using this drug. Especially, patients taking terfenadine, cisapride, pimodizole, or astemizole should not use this medication in combination. It is also safer for patients receiving atazanavir or rilpivirine, and women who are pregnant or breastfeeding should not use this medication. Patients with poor liver function or elderly individuals should use this drug cautiously, as should those with a history of drug allergies. During use, hypersensitivity reactions may occur, such as skin rash, hives, and itching, and if these symptoms appear, use should be stopped immediately. Blood tests are recommended to monitor for abnormalities like decreases in red or white blood cells. Regular liver function tests should be conducted to check for increased liver enzymes, hepatitis or jaundice symptoms, and the medication should be stopped if they arise. Cardiovascular-side effects like elevated blood pressure, myocardial infarction, and arrhythmias may rarely occur, and symptoms should be consulted with a healthcare professional. Gastrointestinal symptoms can include diarrhea, abdominal pain, dyspepsia, nausea, and vomiting. Neuropsychiatric side effects like headache, insomnia, dizziness, and depression have been reported, and rarely neurological symptoms may arise. Respiratory issues can include cough, asthma, and shortness of breath, and if pneumonia symptoms appear, use of the medication should be stopped immediately and a diagnosis sought. Musculoskeletal symptoms such as myalgia and arthralgia can also occur. Dermatological side effects include rashes, itching, hives, hair loss, and in severe cases, serious skin reactions such as Stevens-Johnson syndrome. Ocular side effects reported include blurred vision, tinnitus, and dry eyes. Urinary side effects can include proteinuria, cystitis, and difficulty urinating. Long-term use of this medication may increase the risk of fractures related to osteoporosis, so caution is advised. Hypomagnesemia may rarely occur, and magnesium levels should be monitored periodically during long-term use or when used with certain medications. This medication can increase the risk of bacterial overgrowth in the gastrointestinal tract by suppressing gastric acid secretion, so if diarrhea persists, a doctor should be consulted. Caution is required when driving or operating machinery as drowsiness may occur. There may be interactions with other medications, so particularly with warfarin, methotrexate, antibiotics, advice from a doctor is recommended during combination use. Safety has not been established during pregnancy or lactation, hence it should not be used. Elderly individuals may have higher risks of adverse effects due to declining liver function, so discontinuing the medication should be considered if symptoms arise. Safety in children has not been established, so it is recommended not to use it. In cases of overdose, there are no specific antidotes, so treatment according to symptoms is important. This medication should be swallowed whole without chewing or crushing, and kept out of the reach of children.

Side effects

Rash, hives, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, dry mouth, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, upper and lower limb weakness, sensory dullness, reduced grip strength, language confusion, staggering, delirium, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, lower back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, muscle hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, total cholesterol elevation, triglyceride elevation, BUN elevation, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, lethargy, weight gain, visual abnormalities, loss of appetite, neck stiffness, photosensitive reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticaria, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fracture, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is also safe to store at room temperature, ideally between 1 and 30 degrees Celsius, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Pale yellow, round, enteric-coated tablet

Package unit

Domestic use - 28 tablets/Alu-Alu [(14 tablets/Alu-Alu x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.